ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 57 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,071 | -23.1% | 2,076,400 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $2,016,184 | +11.1% | 2,076,400 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $1,814,774 | -8.3% | 2,076,400 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $1,978,602 | -13.4% | 2,076,400 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $2,284,000 | -9.1% | 2,076,400 | 0.0% | 0.02% | +7.1% |
| Q2 2022 | $2,512,000 | -43.7% | 2,076,400 | 0.0% | 0.01% | -46.2% |
| Q1 2022 | $4,464,000 | -81.9% | 2,076,400 | 0.0% | 0.03% | -78.3% |
| Q4 2021 | $24,647,000 | -23.5% | 2,076,400 | 0.0% | 0.12% | -14.9% |
| Q3 2021 | $32,205,000 | -1.9% | 2,076,400 | +29.0% | 0.14% | -2.1% |
| Q2 2021 | $32,820,000 | -10.4% | 1,610,000 | 0.0% | 0.14% | -9.4% |
| Q1 2021 | $36,611,000 | -17.8% | 1,610,000 | 0.0% | 0.16% | -5.4% |
| Q4 2020 | $44,517,000 | – | 1,610,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |